Steven Jay Sheris, MD - Medicare Cardiovascular Disease (cardiology) in New Providence, NJ

Steven Jay Sheris, MD is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in New Providence, New Jersey. He went to Rutgers R W Johnson Medical School (cam/new Bruns/pisc) and graduated in 1988 and has 36 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Practice Associates Medical Group and his current practice location is 571 Central Ave Ste 115, Associates In Cardiovascular Disease Llc, New Providence, New Jersey. You can reach out to his office (for appointments etc.) via phone at (908) 464-4200.

Steven Jay Sheris is licensed to practice in New Jersey (license number 25MA05375300) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1629062187.

Contact Information

Steven Jay Sheris, MD
571 Central Ave Ste 115, Associates In Cardiovascular Disease Llc,
New Providence, NJ 07974-1547
(908) 464-4200
(908) 464-1332



Physician's Profile

Full NameSteven Jay Sheris
GenderMale
SpecialityCardiovascular Disease (cardiology)
Experience36 Years
Location571 Central Ave Ste 115, New Providence, New Jersey
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Steven Jay Sheris attended and graduated from Rutgers R W Johnson Medical School (cam/new Bruns/pisc) in 1988
  NPI Data:
  • NPI Number: 1629062187
  • Provider Enumeration Date: 09/09/2005
  • Last Update Date: 05/09/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 3678560489
  • Enrollment ID: I20040426001003

Medical Identifiers

Medical identifiers for Steven Jay Sheris such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1629062187NPI-NPPES
8571406MedicaidNJ

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0000XInternal Medicine - Cardiovascular Disease 25MA05375300 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Overlook Medical CenterSummit, NJHospital
Morristown Medical CenterMorristown, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Practice Associates Medical Group58907031771116

News Archive

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

InterMune, Inc. announced today that the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.

Study determines impact of HIV on anal cancer incidence in the U.S.

The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute.

New drug to treat pancreatic cancer shows promising results in clinical trial

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.

New research demonstrates how geographic profiling can help combat infectious diseases

Every 30 seconds, infectious diseases such as malaria, HIV/AIDS and tuberculosis kill as many people as Jack the Ripper did in his entire career. New research published in BioMed Central's open access journal International Journal of Health Geographics demonstrates how the mathematical model of geographic profiling, used in the hunt for serial killers, can help combat infectious diseases.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Steven Jay Sheris allows following entities to bill medicare on his behalf.
Entity NameCardiovascular Health Consultants, P.a.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437291739
PECOS PAC ID: 8325934706
Enrollment ID: O20040224000028

News Archive

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

InterMune, Inc. announced today that the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.

Study determines impact of HIV on anal cancer incidence in the U.S.

The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute.

New drug to treat pancreatic cancer shows promising results in clinical trial

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.

New research demonstrates how geographic profiling can help combat infectious diseases

Every 30 seconds, infectious diseases such as malaria, HIV/AIDS and tuberculosis kill as many people as Jack the Ripper did in his entire career. New research published in BioMed Central's open access journal International Journal of Health Geographics demonstrates how the mathematical model of geographic profiling, used in the hunt for serial killers, can help combat infectious diseases.

Read more Medical News

› Verified 9 days ago

Entity NamePractice Associates Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1427016385
PECOS PAC ID: 5890703177
Enrollment ID: O20060330000690

News Archive

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

InterMune, Inc. announced today that the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.

Study determines impact of HIV on anal cancer incidence in the U.S.

The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute.

New drug to treat pancreatic cancer shows promising results in clinical trial

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.

New research demonstrates how geographic profiling can help combat infectious diseases

Every 30 seconds, infectious diseases such as malaria, HIV/AIDS and tuberculosis kill as many people as Jack the Ripper did in his entire career. New research published in BioMed Central's open access journal International Journal of Health Geographics demonstrates how the mathematical model of geographic profiling, used in the hunt for serial killers, can help combat infectious diseases.

Read more Medical News

› Verified 9 days ago

Entity NameAtlantic Health Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144720459
PECOS PAC ID: 9335494509
Enrollment ID: O20180613000046

News Archive

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

InterMune, Inc. announced today that the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.

Study determines impact of HIV on anal cancer incidence in the U.S.

The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute.

New drug to treat pancreatic cancer shows promising results in clinical trial

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.

New research demonstrates how geographic profiling can help combat infectious diseases

Every 30 seconds, infectious diseases such as malaria, HIV/AIDS and tuberculosis kill as many people as Jack the Ripper did in his entire career. New research published in BioMed Central's open access journal International Journal of Health Geographics demonstrates how the mathematical model of geographic profiling, used in the hunt for serial killers, can help combat infectious diseases.

Read more Medical News

› Verified 9 days ago

Entity NameAtlantic Advanced Urgent Care
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1104309277
PECOS PAC ID: 4385986330
Enrollment ID: O20190424000040

News Archive

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

InterMune, Inc. announced today that the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.

Study determines impact of HIV on anal cancer incidence in the U.S.

The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute.

New drug to treat pancreatic cancer shows promising results in clinical trial

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.

New research demonstrates how geographic profiling can help combat infectious diseases

Every 30 seconds, infectious diseases such as malaria, HIV/AIDS and tuberculosis kill as many people as Jack the Ripper did in his entire career. New research published in BioMed Central's open access journal International Journal of Health Geographics demonstrates how the mathematical model of geographic profiling, used in the hunt for serial killers, can help combat infectious diseases.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Steven Jay Sheris is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Steven Jay Sheris, MD
Po Box 416457, Practice Associates Medical Group,
Boston, MA 02241-6457

Ph: (973) 656-6280
Steven Jay Sheris, MD
571 Central Ave Ste 115, Associates In Cardiovascular Disease Llc,
New Providence, NJ 07974-1547

Ph: (908) 464-4200

News Archive

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

InterMune, Inc. announced today that the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.

Study determines impact of HIV on anal cancer incidence in the U.S.

The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute.

New drug to treat pancreatic cancer shows promising results in clinical trial

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.

New research demonstrates how geographic profiling can help combat infectious diseases

Every 30 seconds, infectious diseases such as malaria, HIV/AIDS and tuberculosis kill as many people as Jack the Ripper did in his entire career. New research published in BioMed Central's open access journal International Journal of Health Geographics demonstrates how the mathematical model of geographic profiling, used in the hunt for serial killers, can help combat infectious diseases.

Read more News

› Verified 9 days ago


Internal Medicine Doctors in New Providence, NJ

Dr. Khimya I Vaswani, MD
Cardiovascular Disease
Medicare: Not Enrolled in Medicare
Practice Location: 1806 Springfield Ave, New Providence, NJ 07974
Phone: 973-912-0104    Fax: 973-376-7040
Robert John Mich, MD
Cardiovascular Disease
Medicare: Not Enrolled in Medicare
Practice Location: 571 Central Ave Ste 115, Associates In Cardiovascular Disease Llc, New Providence, NJ 07974
Phone: 908-464-4200    Fax: 908-464-1332
John Patrick Farry, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 571 Central Ave Ste 115, Associates In Cardiovascular Disease Llc, New Providence, NJ 07974
Phone: 908-464-4200    Fax: 908-464-1332
Robert L Rosenbaum, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 890 Mountain Ave, New Providence, NJ 07974
Phone: 908-277-8667    Fax: 908-277-8707
Dr. James John Hakim, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 571 Central Ave Ste 112, New Providence, NJ 07974
Phone: 908-464-7300    Fax: 908-464-7350
David Bartov, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 571 Central Ave Ste 115, Associates In Cardiovascular Disease, New Providence, NJ 07974
Phone: 908-464-2000    Fax: 908-464-1332
Dr. Sushmita Srivastav, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 535 Mountain Ave, New Providence, NJ 07974
Phone: 903-516-9245    Fax: 908-516-9265

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.